These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2896327)

  • 1. [Treatment of glaucoma with beta receptor blockers. Significance of adrenergic receptors of the beta-2 subtype for their effect on intraocular pressure].
    Noack E
    Ophthalmologica; 1988; 196(2):76-81. PubMed ID: 2896327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiglaucomatous effectiveness of beta receptor blockers with special reference to metipranolol].
    Noack E
    Klin Monbl Augenheilkd; 1986 Jul; 189(1):1-3. PubMed ID: 2876128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beta-adrenergic blocking agents and the treatment of glaucoma.
    Zimmerman TJ; Boger WP
    Surv Ophthalmol; 1979; 23(6):347-62. PubMed ID: 37605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of beta blockers in ophthalmology].
    Cvetković D
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():51-3. PubMed ID: 18193811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observations on the pharmacology of glaucoma.
    Leopold IH; Duzman E
    Annu Rev Pharmacol Toxicol; 1986; 26():401-26. PubMed ID: 2872854
    [No Abstract]   [Full Text] [Related]  

  • 6. Are beta-adrenergic mechanisms involved in ocular hypotensive actions of adrenergic drugs?
    Chiou GC; Watanabe K; McLaughlin MA; Liu HK
    Ophthalmic Res; 1985; 17(1):49-53. PubMed ID: 2858837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism of action of beta-blockers].
    Martin X
    Ophtalmologie; 1990; 4(2):154-5. PubMed ID: 1978278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuro-hormonal regulation of aqueous humor dynamics as the basis of glaucoma pharmacotherapy. Part I. Aqueous humor secretion].
    Terelak-Borys B; Liberek I
    Klin Oczna; 2007; 109(1-3):60-3. PubMed ID: 17687916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vascular effect and intraocular pressure-reducing effect of beta blockers].
    Merté HJ
    Klin Monbl Augenheilkd; 1986 Nov; 189(5):396-7. PubMed ID: 2879957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of aqueous humor flow.
    McLaren JW
    Exp Eye Res; 2009 Apr; 88(4):641-7. PubMed ID: 19026639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of glaucoma with beta receptor blockers].
    Demmler N
    Fortschr Med; 1980 Jun; 98(23):880-5. PubMed ID: 6106627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-Blockers and the eye: an overview.
    Katz IM
    Ann Ophthalmol; 1978 Jul; 10(7):847-50. PubMed ID: 28061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vanadate and aqueous humor dynamics. Proctor Lecture.
    Becker B
    Invest Ophthalmol Vis Sci; 1980 Oct; 19(10):1156-65. PubMed ID: 6106642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: significance for combination therapy in glaucoma.
    Crooke A; Huete-Toral F; Martínez-Águila A; Martín-Gil A; Pintor J
    J Pharmacol Exp Ther; 2013 Jul; 346(1):138-45. PubMed ID: 23591996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Beta-stimulants and beta-blockers. Their role in the medical treatment of open-angle glaucoma].
    Weekers R; Collignon-Brach J
    J Fr Ophtalmol; 1981; 4(2):149-55. PubMed ID: 6113257
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mode of action, clinical profile and significance of beta-blockers in antiglaucoma therapy].
    Schlote T
    Klin Monbl Augenheilkd; 2013 Feb; 230(2):120-6. PubMed ID: 23430677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The results of treating aphakic glaucoma with beta-blockers].
    Kartasheva EA; Pimneva IV
    Vestn Oftalmol; 1999; 115(5):32-3. PubMed ID: 10582020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shortterm "escape" and longterm "drift." The dissipation effects of the beta adrenergic blocking agents.
    Boger WP
    Surv Ophthalmol; 1983 Dec; 28 Suppl():235-42. PubMed ID: 6141645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inflow and outflow of anti-glaucoma drugs.
    Woodward DF; Gil DW
    Trends Pharmacol Sci; 2004 May; 25(5):238-41. PubMed ID: 15120486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new approach to the medical management of glaucoma, from the bench to the clinic, and beyond: the Proctor Lecture.
    Bito LZ
    Invest Ophthalmol Vis Sci; 2001 May; 42(6):1126-33. PubMed ID: 11328718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.